ConductScience.org, home

Paper38360641

Tumorigenic and tumoricidal properties of exosomes in cancers; a forward look.

Abbasi-Malati Z and 7 others. Cell Commun Signal, 2024. Cited by 18 papers, by iCite.

Cite this record

ConductScience Library. Tumorigenic and tumoricidal properties of exosomes in cancers; a forward look. Papers, record 38360641. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38360641

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Tumorigenic and tumoricidal properties of exosomes in cancers; a forward look.
PubMed
Journal
Cell Commun Signal
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
18
iCite
Relative citation ratio, by iCite
3.21, provisional
iCite
Revised in PubMed
2026-09-21
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Abbasi-Malati ZZahra
2Azizi SGSeyed Ghader
3Milani SZSoheil Zamen
4Serej ZAZeinab Aliyari
5Mardi NNarges
6Amiri ZZahra
7Sanaat ZZohreh
8Rahbarghazi RReza

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
ExosomesMajor topic
NeoplasmsMajor topic
Extracellular VesiclesMajor topic
Humans
Carcinogenesis
Signal Transduction
Tumor Microenvironment

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
71399Tabriz University of Medical SciencesPubMed

Source PubMed

Download CSV of grants

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT06871904Fibrosis-Modulating Effects of Metformin and Pirfenidone in Oral Submucous FibrosisBackground

Source ClinicalTrials.gov

Download CSV of trials

References295

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
125320245Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1.Blood2014https://conductscience.org/library/papers/25320245PubMed
232269736Exosome-mediated miRNA delivery promotes liver cancer EMT and metastasis.Am J Transl Res2020https://conductscience.org/library/papers/32269736PubMed
333330451Exosomal miRNA-16-5p Derived From M1 Macrophages Enhances T Cell-Dependent Immune Response by Regulating PD-L1 in Gastric Cancer.Front Cell Dev Biol2020https://conductscience.org/library/papers/33330451PubMed
435158768Exosomes in Cancer Therapy.Cancers (Basel)2022https://conductscience.org/library/papers/35158768PubMed
536932387Exosome-derived circCCAR1 promotes CD8 + T-cell dysfunction and anti-PD1 resistance in hepatocellular carcinoma.Mol Cancer2023https://conductscience.org/library/papers/36932387PubMed
634093824Tumor-derived Exosome Promotes Metastasis via Altering its Phenotype and Inclusions.J Cancer2021https://conductscience.org/library/papers/34093824PubMed
734292880Exosomal miRNA-205 promotes breast cancer chemoresistance and tumorigenesis through E2F1.Aging (Albany NY)2021https://conductscience.org/library/papers/34292880PubMed
834717769Mesenchymal stem cells-derived exosomes for drug delivery.Stem Cell Res Ther2021https://conductscience.org/library/papers/34717769PubMed
933253966Pancreatic cancer-targeting exosomes for enhancing immunotherapy and reprogramming tumor microenvironment.Biomaterials2021https://conductscience.org/library/papers/33253966PubMed
1034560422M1 macrophage exosomes engineered to foster M1 polarization and target the IL-4 receptor inhibit tumor growth by reprogramming tumor-associated macrophages into M1-like macrophages.Biomaterials2021https://conductscience.org/library/papers/34560422PubMed
1135071216Review on Strategies and Technologies for Exosome Isolation and Purification.Front Bioeng Biotechnol2021https://conductscience.org/library/papers/35071216PubMed
1236430452Harnessing Normal and Engineered Mesenchymal Stem Cells Derived Exosomes for Cancer Therapy: Opportunity and Challenges.Int J Mol Sci2022https://conductscience.org/library/papers/36430452PubMed
1335700679Recent progress of dendritic cell-derived exosomes (Dex) as an anti-cancer nanovaccine.Biomed Pharmacother2022https://conductscience.org/library/papers/35700679PubMed
1432268136Breast cancer-derived exosomes regulate cell invasion and metastasis in breast cancer via miR-146a to activate cancer associated fibroblasts in tumor microenvironment.Exp Cell Res2020https://conductscience.org/library/papers/32268136PubMed
1531951852lncRNA UCA1 Promotes Gefitinib Resistance as a ceRNA to Target FOSL2 by Sponging miR-143 in Non-small Cell Lung Cancer.Mol Ther Nucleic Acids2020https://conductscience.org/library/papers/31951852PubMed
1633061571Adipose Mesenchymal Stem Cell-Derived Exosomal microRNA-1236 Reduces Resistance of Breast Cancer Cells to Cisplatin by Suppressing SLC9A1 and the Wnt/β-Catenin Signaling.Cancer Manag Res2020https://conductscience.org/library/papers/33061571PubMed
1736093435Exosomal lncRNA PCAT1 Promotes Tumor Circulating Cell-Mediated Colorectal Cancer Liver Metastasis by Regulating the Activity of the miR-329-3p/Netrin-1-CD146 Complex.J Immunol Res2022https://conductscience.org/library/papers/36093435PubMed
1835722996CAFs-derived small extracellular vesicles circN4BP2L2 promotes proliferation and metastasis of colorectal cancer via miR-664b-3p/HMGB3 pathway.Cancer Biol Ther2022https://conductscience.org/library/papers/35722996PubMed
1933738282Could Extracellular Vesicles Contribute to Generation or Awakening of "Sleepy" Metastatic Niches?Front Cell Dev Biol2021https://conductscience.org/library/papers/33738282PubMed
2033823894Chemotherapy-elicited exosomal miR-378a-3p and miR-378d promote breast cancer stemness and chemoresistance via the activation of EZH2/STAT3 signaling.J Exp Clin Cancer Res2021https://conductscience.org/library/papers/33823894PubMed

See all 295 referencesDownload CSV of references

Cited by13

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 18 citations.

PMIDTitleJournalYearIn PapersSource
42016928Transforming Duchenne muscular dystrophy therapy: The multifaceted role of extracellular vesicles and exosomes.Biochem Biophys Rep2026https://conductscience.org/library/papers/42016928PubMed
42010708Application of dendritic cell extracellular vesicles as a valid nanoparticle platform for cancer therapies: a narrative review.Stem Cell Res Ther2026https://conductscience.org/library/papers/42010708PubMed
41867505Regenerative strategies for post-prostatectomy incontinence: stem cells, exosomes, and the path to clinical resolution.Am J Clin Exp Urol2026https://conductscience.org/library/papers/41867505PubMed
41514320Microvesicles, exosomes and their combinations with cytoplasmic organelles: from their discovery to their innovative roles in clinical medicine.Biol Direct2026https://conductscience.org/library/papers/41514320PubMed
41322395Autophagy stimulation influenced the angiogenesis and metastasis behavior of human triple-negative breast cancer cells.Bioimpacts2025https://conductscience.org/library/papers/41322395PubMed
40922748Hypoxic exosomes alleviated the spinal cord injury after ischemic/reperfusion in a rat model.Adv Pharm Bull2025https://conductscience.org/library/papers/40922748PubMed
40598419Peritoneal cavity-derived small extracellular vesicles from aged tumor-naïve hosts promote ovarian cancer adhesion and invasion.Cell Commun Signal2025https://conductscience.org/library/papers/40598419PubMed
40452185Cancer-derived extracellular vesicles in natural killer cell immune evasion: Molecular mechanisms and therapeutic insights.Mol Ther2025https://conductscience.org/library/papers/40452185PubMed
40272656Modeling of cancer stem cells and the tumor microenvironment Via NT2/D1 cells to probe pathology and treatment for cancer and beyond.Discov Oncol2025https://conductscience.org/library/papers/40272656PubMed
40256240Role of Toll-like receptors in exosome biogenesis and angiogenesis capacity.Bioimpacts2025https://conductscience.org/library/papers/40256240PubMed
40100465Exosomes derived from natural killer cells: transforming immunotherapy for aggressive breast cancer.Med Oncol2025https://conductscience.org/library/papers/40100465PubMed
39696346Exosomes and breast cancer angiogenesis; Highlights in intercellular communication.Cancer Cell Int2024https://conductscience.org/library/papers/39696346PubMed
38943222Therapeutic potential of extracellular vesicles from diverse sources in cancer treatment.Eur J Med Res2024https://conductscience.org/library/papers/38943222PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/38360641

GET https://conductscience.org/api/papers/v1/38360641/references?page=2